Chief Operating Officer @ (May 2023 - December 2025)
President @ Academy for Health & Lifespan Research (October 2018 - December 2023)
Executive Vice President and Chief Operating Officer @ (April 2020 - May 2023)
Vice President corporate development and Strategy @ (July 2018 - April 2020)
Vice President and Managing Director France at Biogen @ (June 2015 - June 2018)
Country president Portugal @ (February 2012 - June 2015)
Sales and Marketing Director Europe @ (October 2009 - February 2012)
US and International brand director @ Eli Lilly (April 2007 - October 2009)
David Setboun Education
Harvard Business School 2018-2018
Massachusetts Institute of Technology
Leading Entreprise Transformation Program
2013-2013
Ivey Business School at Western University
MBA Exchange Program
2001-2001
HEC Paris
MBA
2000-2001
Paris-Sud University (Paris XI)
Doctor of Pharmacy (Pharm.D.)
1992-1998
David Setboun Skills
Market Access
Pharmaceutical Industry
Sales Effectiveness
Market Research
Management
Oncology
Business Development
Hospital Sales
Strategy
Biotechnology
Cardiology
CRM
Marketing
Sales
Pharmaceutical Sales
Start-ups
Strategic Thinking
Product Management
Executive Management
P&L Management
Clinical Trials
Life Sciences
Leadership
product launch
Cross-functional Team Leadership
New Business Development
Sales Management
Business Strategy
Public Speaking
Change Management
PowerPoint
Project Management
Start Ups
David Setboun Summary
David Setboun, based in Boston, MA, US, is currently a Chief Executive Officer at PharmatrophiX, Inc.. David Setboun brings experience from previous roles at Alkeus Pharmaceuticals, Inc., Academy for Health & Lifespan Research, Brainstorm Cell Therapeutics and Life Biosciences. David Setboun holds a 2018 - 2018 Harvard Business School. With a robust skill set that includes Market Access, Pharmaceutical Industry, Sales Effectiveness, Market Research, Management and more. David Setboun has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different David Setboun?
Find contact details for 700 million professionals.